|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, March 10, 2018 ) Nuclear Medicine Radiopharmaceuticals Market by Diagnostics (SPECT, PET), by Therapeutics (Beta Emitters, Alpha Emitters, Brachytherapy), by Application (cardiology, lymphoma, thyroid, neurology oncology) and by Region – Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2021
Global Nuclear Medicine/Radiopharmaceutical MarketResearch Report has the complete assessment of the latest trends of the Nuclear Medicine/Radiopharmaceuticals market. The report focuses on the manufacturing challenges that are being faced and provides the solutions and the strategies that have been implemented to overcome the problems. Deep researches and analysis were done during the preparation of the report.
The Global Nuclear Medicine/Radiopharmaceutical Market is expected to reach 9,275.3 million by 2021. Nuclear medicinal market is mainly classified into type (diagnosis & therapeutics), application and end-users.
Download sample pages of this report: http://bit.ly/2Fn4yhl
Increasing incidence of cancer and cardiac ailments, immense technological advancements, increasing demand SPECT and PET applications and also the growing public awareness for healthcare are fuelling the market growth for Radiopharmaceuticals.Further, Integration of X ray tomography (CT) into SPECT has recently emerged as a excellent diagnostic tool in medical imaging and is considered to be a driving factor for the growth of the market. Strict regulatory framework which pose as a hurdle to translational research and clinical investigations and reimbursement issues are blocking the growth of the market. In addition, shorter half-life of radiopharmaceuticals and competition from orthodox diagnostic procedures are also restraining the global nuclear medicine Radioisotopes market.
The global market is segmented on the basis of type, application, procedural volume, and region. On the basis of type, the diagnostic radiopharmaceuticals segment is expected to command the largest share of the global market; it is also expected to grow at the highest CAGR during the forecast period. The large market share and high growth rate of this segment can be attributed to the production of MO-99 in the U.S., approval of radiopharmaceuticals by the FDA, new irradiation facility in Germany, installation of PET scanners in India, investments by the government in the Rest of Asia-Pacific, and initiatives of IAEA (International Atomic Energy Agency).
On the basis of application, the SPECT applications segment is estimated to account for the largest share of the global nuclear medicine market. However, the PET segment is projected to register the highest growth rate in the forecast period. A number of factors, such as advances in PET imaging techniques and equipment and the introduction of new PET radiotracers, are making it the desired choice for diagnosis.
In the coming years, the market is expected to witness the highest growth in the Asia-Pacific region. This regional segment is also expected to account for the largest share of the global market. This can be attributed to the installations of PET scanners and increased production of radiopharmaceuticals for therapeutic purposes in India, aging population, high healthcare expenditure in Japan and China, and initiatives by the Australian government.
Some of the major players :
Cardinal Health Inc. (U.S.), Mallinckrodt plc (Ireland), GE Healthcare (U.K.), Lantheus Medical Imaging, Inc. (U.S.), Bayer AG (Germany), Bracco Imaging S.p.A (Italy), Eczacibasi-Monrol Nuclear Products (Turkey), Nordion, Inc. (Canada), Advanced Accelerator Applications S.A. (France), and IBA Molecular Imaging (Belgium).
Top Players :
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
Siemens
Download sample pages of this report: http://bit.ly/2Fn4yhl
About Us:
Key Market Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns.
Key Market Insights
sambit kumar
8007533694
sambit.kumar@kminsights.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
